AI pre-screen
Possible
64/100
Meets the core MDD inclusion criteria; two items to confirm at the screening visit.
Screening detail
Meets criteria
Meets DSM-5-TR criteria for current MDD (MINI-confirmed)
Current episode between 6 weeks and 24 months
Age within 18-74
To confirm
MADRS severity to confirm at screening
First lifetime episode onset before age 50 (confirm)
Decide on Candidate
Candidate already completed the screening questionnaire. Accepting unlocks their contact so you can message them here. We do not email a calendar.
AI-assisted decision support. A qualified team member must review and decide.
Messages
Applied Aug 17 · via ClinicalTrials.gov
No messages yet.
Accept this applicant to unlock two-way messaging.
Contact & details
Contact unlocks when you accept
Source: ClinicalTrials.gov
Applied Aug 17
Applied to
Azetukalner vs Placebo in Major Depressive Disorder (X-NOVA3)
NCT07076407
Stage advances from what you do. Accepting marks them likely eligible; booking a visit moves them to screening.
Patient portal
Accept this applicant first, then you can give them portal access.
Notes team-only
Type @ to pull a teammate into this thread instead of CC-ing them on an email.
No notes yet. Jot context only your team sees.
Tasks
No to-dos yet.
Screening answers
Can travel to the study site
Yes
Currently in another trial
No
Pregnant / planning pregnancy
No
Can give own consent
Yes
Documents
No documents shared.
Timeline
application received
2026-08-17 06:34 · you
ready for study-team review
2026-08-17 06:34 · you